Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation.

PLoS One · 2012 · PMC3466211 · PMID 23056525

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP = 4.35×10 −14actually significant

Another protein with a molecular size of 8766 m/z also showed a highly significant difference ( P = 4.35×10 −14 ) between pancreatic cancer patients and healthy controls ( Fig. 2 , indicated by quadruple asterisks).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.